Millennium Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,966,005
| Closed | -$261K | – | 5868 |
|
|
2020
Q3 | $261K | Buy |
4,966,005
+4,290,874
| +636% | +$178M | 0.32% | 37 |
|
|
2020
Q2 | $22.5M | Sell |
675,131
-79,939
| -11% | -$2.55M | 0.03% | 667 |
|
|
2020
Q1 | $20.5M | Buy |
+755,070
| New | +$21M | 0.05% | 438 |
|
|
2019
Q4 | – | Sell |
-428,336
| Closed | -$5.55M | – | 4835 |
|
|
2019
Q3 | $5.55M | Buy |
428,336
+46,769
| +12% | +$565K | 0.01% | 1719 |
|
|
2019
Q2 | $4.75M | Buy |
381,567
+219,939
| +136% | +$2.92M | 0.01% | 1821 |
|
|
2019
Q1 | $2.35M | Sell |
161,628
-96,844
| -37% | -$1.24M | ﹤0.01% | 2308 |
|
|
2018
Q4 | $2.85M | Sell |
258,472
-16,277
| -6% | -$227K | ﹤0.01% | 1982 |
|
|
2018
Q3 | $7.23M | Buy |
+274,749
| New | +$7.43M | 0.01% | 1540 |
|
|
2018
Q2 | – | Sell |
-669,149
| Closed | -$12.1M | – | 4358 |
|
|
2018
Q1 | $12.1M | Sell |
669,149
-100,543
| -13% | -$1.68M | 0.02% | 1202 |
|
|
2017
Q4 | $10.7M | Buy |
+769,692
| New | +$10.4M | 0.01% | 1286 |
|
|
2017
Q2 | – | Sell |
-122,858
| Closed | -$1.64M | – | 4045 |
|
|
2017
Q1 | $1.64M | Sell |
122,858
-1,121,716
| -90% | -$17.6M | ﹤0.01% | 2117 |
|
|
2016
Q4 | $18.7M | Sell |
1,244,574
-322,593
| -21% | -$4.26M | 0.04% | 621 |
|
|
2016
Q3 | $18.3M | Buy |
1,567,167
+1,085,024
| +225% | +$12.8M | 0.03% | 617 |
|
|
2016
Q2 | $5.21M | Sell |
482,143
-70,171
| -13% | -$724K | 0.01% | 1237 |
|
|
2016
Q1 | $5.1M | Sell |
552,314
-399,361
| -42% | -$4.3M | 0.01% | 1249 |
|
|
2015
Q4 | $14.1M | Sell |
951,675
-210,739
| -18% | -$3.53M | 0.03% | 732 |
|
|
2015
Q3 | $19.1M | Buy |
1,162,414
+263,292
| +29% | +$5.39M | 0.04% | 588 |
|
|
2015
Q2 | $20.5M | Sell |
899,122
-113,753
| -11% | -$2.27M | 0.04% | 614 |
|
|
2015
Q1 | $15.4M | Sell |
1,012,875
-161,528
| -14% | -$2.1M | 0.03% | 811 |
|
|
2014
Q4 | $14.1M | Buy |
1,174,403
+167,569
| +17% | +$1.92M | 0.03% | 779 |
|
|
2014
Q3 | $11.4M | Buy |
1,006,834
+245,666
| +32% | +$2.8M | 0.03% | 798 |
|
|
2014
Q2 | $9.2M | Sell |
761,168
-123,680
| -14% | -$1.46M | 0.03% | 862 |
|
|
2014
Q1 | $10.3M | Buy |
884,848
+233,493
| +36% | +$3.95M | 0.03% | 787 |
|
|
2013
Q4 | $11.5M | Buy |
651,355
+160,647
| +33% | +$2.7M | 0.04% | 622 |
|
|
2013
Q3 | $7.06M | Sell |
490,708
-100,227
| -17% | -$1.53M | 0.02% | 919 |
|
|
2013
Q2 | $8.9M | Buy |
+590,935
| New | +$7.8M | 0.03% | 679 |
|
Millennium Management's MNTA Position: Q4 2020 in Review
Millennium Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,966,005 shares — an estimated $261K sold.
Millennium Management first reported a position in MNTA in Q2 2013 and held it in 26 quarters. The position peaked at $22.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Millennium Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Millennium Management sold 4,966,005 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $261K.
- Millennium Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
- Millennium Management's Momenta Pharmaceuticals, Inc. position peaked at $22.5M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.